One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Effect of Hydroxychloroquine on Clinical Status at 14 Days in Hospitalized Patients With COVID-19
Wesley H. Self, MD, MPH1; Matthew W. Semler, MD2; Lindsay M. Leither, DO3,4; Jonathan D. Casey, MD, MSc2; Derek C. Angus, MD, MPH5; Roy G. Brower, MD6; Steven Y. Chang, MD, PhD7; Sean P. Collins, MD1; John C. Eppensteiner, MD8; Michael R. Filbin, MD9; D. Clark Files, MD10; Kevin W. Gibbs, MD10; Adit A. Ginde, MD, MPH11; Michelle N. Gong, MD, MS12; Frank E. Harrell Jr, PhD13; Douglas L. Hayden, PhD14; Catherine L. Hough, MD, MSc15; Nicholas J. Johnson, MD16; Akram Khan, MD15; Christopher J. Lindsell, PhD13; Michael A. Matthay, MD17; Marc Moss, MD18; Pauline K. Park, MD19; Todd W. Rice, MD2; Bryce R. H. Robinson, MD, MS20; David A. Schoenfeld, PhD14; Nathan I. Shapiro, MD, MPH21; Jay S. Steingrub, MD22; Christine A. Ulysse, MS14; Alexandra Weissman, MD, MPH23; Donald M. Yealy, MD23; B. Taylor Thompson, MD24; Samuel M. Brown, MD, MS3,4; for the National Heart, Lung, and Blood Institute PETAL Clinical Trials Network
doi : 10.1001/jama.2020.22240
JAMA. 2020;324(21):2165-2176
Data on the efficacy of hydroxychloroquine for the treatment of coronavirus disease 2019 (COVID-19) are needed.
Effect of Cannabidiol and ?9-Tetrahydrocannabinol on Driving Performance
Thomas R. Arkell, PhD1,2,3,4; Frederick Vinckenbosch, MSc4; Richard C. Kevin, PhD1,2,5; Eef L. Theunissen, PhD4; Iain S. McGregor, PhD1,2,5; Johannes G. Ramaekers, PhD4
doi : 10.1001/jama.2020.21218
JAMA. 2020;324(21):2177-2186
Cannabis use has been associated with increased crash risk, but the effect of cannabidiol (CBD) on driving is unclear.
Association of Use of a Meningococcus Group B Vaccine With Group B Invasive Meningococcal Disease Among Children in Portugal
Fernanda M. P. Rodrigues, PhD1,2; Robin Marlow, PhD3; Maria Jo?o Sim?es, PhD4; Leon Danon, PhD5,6; Shamez Ladhani, PhD7,8; Adam Finn, PhD3
doi : 10.1001/jama.2020.20449
JAMA. 2020;324(21):2187-2194
A 4-component meningococcus group B vaccine (4CMenB) is the only vaccine in use to prevent group B invasive meningococcal disease in young children, but no matched controlled studies have evaluated it.
Trends in Dispensing of Zolpidem and Low-Dose Trazodone Among Commercially Insured Adults in the United States, 2011-2018
Jenna Wong, PhD1; Mara Murray Horwitz, MD, MPH2; Suzanne M. Bertisch, MD, MPH3; Shoshana J. Herzig, MD, MPH4; Daniel J. Buysse, MD5; Sengwee Toh, ScD1
doi : 10.1001/jama.2020.19224
JAMA. 2020;324(21):2211-2213
Therapy for Early COVID-19
Peter S. Kim, MD1; Sarah W. Read, MD, MHS1; Anthony S. Fauci, MD2
doi : 10.1001/jama.2020.22813
JAMA. 2020;324(21):2149-2150
The Challenges Ahead With Monoclonal Antibodies
Robert H. Goldstein, MD, PhD1,3; Rochelle P. Walensky, MD, MPH2,3
doi : 10.1001/jama.2020.21872
JAMA. 2020;324(21):2151-2152
The Need for More and Better Testing for COVID-19
Yukari C. Manabe, MD1; Joshua S. Sharfstein, MD2; Katrina Armstrong, MD3
doi : 10.1001/jama.2020.21694
JAMA. 2020;324(21):2153-2154
Hospital-Acquired SARS-CoV-2 Infection
Aaron Richterman, MD1; Eric A. Meyerowitz, MD2; Muge Cevik, MD3
doi : 10.1001/jama.2020.21399
JAMA. 2020;324(21):2155-2156
Health Policy in the Supreme Court and a New Conservative Majority
Lawrence O. Gostin, JD1; Wendy E. Parmet, JD2; Sara Rosenbaum, JD3
doi : 10.1001/jama.2020.21987
JAMA. 2020;324(21):2157-2158
Always More to Be Done
Ramya Sampath, BA1
doi : 10.1001/jama.2020.22783
JAMA. 2020;324(21):2159-2160
Misguided Use of Hydroxychloroquine for COVID-19
Michael S. Saag, MD1
doi : 10.1001/jama.2020.22389
JAMA. 2020;324(21):2161-2162
Cannabis and Impaired Driving
Thomas B. Cole, MD, MPH1; Richard Saitz, MD, MPH1,2,3
doi : 10.1001/jama.2020.18544
JAMA. 2020;324(21):2163-2164
Hearing Loss in Children
Judith E. C. Lieu, MD, MSPH1; Margaret Kenna, MD, MPH2,3; Samantha Anne, MD4; Lisa Davidson, PhD1
doi : 10.1001/jama.2020.17647
JAMA. 2020;324(21):2195-2205
Hearing loss in children is common and by age 18 years, affects nearly 1 of every 5 children. Without hearing rehabilitation, hearing loss can cause detrimental effects on speech, language, developmental, educational, and cognitive outcomes in children.
Gastric Balloons for Weight Loss in 2020
Dana A. Telem, MD, MPH1,2; Amir A. Ghaferi, MD, MS1,2
doi : 10.1001/jama.2020.14862
JAMA. 2020;324(21):2206-2207
Recommendations for Follow-up Colonoscopy After Polypectomy
Cecelia Zhang, MD1; Adam S. Cifu, MD2; Amit Patel, MD1,3
doi : 10.1001/jama.2020.15001
JAMA. 2020;324(21):2208-2209
Younger Adults Caught in COVID-19 Crosshairs as Demographics Shift
Jennifer Abbasi
doi : 10.1001/jama.2020.21913
JAMA. 2020;324(21):2141-2143
Driving Under the Influence of CBD or THC—Is There a Difference?
Rita Rubin, MA
doi : 10.1001/jama.2020.22181
JAMA. 2020;324(21):2144-2145
Essential Medicines Identified for Future Public Health Emergencies
Rebecca Voelker, MSJ
doi : 10.1001/jama.2020.23157
JAMA. 2020;324(21):2147
New Partnership Aims to Intercept Illegal Drugs and Devices
Rebecca Voelker, MSJ
doi : 10.1001/jama.2020.22864
JAMA. 2020;324(21):2147
Ivermectin Lotion for Head Lice No Longer Needs a Prescription
Rebecca Voelker, MSJ
doi : 10.1001/jama.2020.23159
JAMA. 2020;324(21):2147
How Targeting Fat Cells’ Estrogen Receptors Could Fight Obesity
Tracy Hampton, PhD
doi : 10.1001/jama.2020.22148
JAMA. 2020;324(21):2146
Urinary Diversion
Andrew T. Lenis, MD, MS1; Patrick M. Lec, MD1; Karim Chamie, MD, MSHS1
doi : 10.1001/jama.2020.17604
JAMA. 2020;324(21):2222
Prejudices of a Referenced Philosopher
Yusur M. Alsalihi, BA1; Evelena Cousin-Peterson, MD1; Paul C. Kuo, MD, MBA, MS1
doi : 10.1001/jama.2020.20083
JAMA. 2020;324(21):2213-2214
Prejudices of a Referenced Philosopher—Reply
Donald M. Berwick, MD, MPP1
doi : 10.1001/jama.2020.20086
JAMA. 2020;324(21):2214
Developments in Heart Failure With Reduced Ejection Fraction
Robert Dowling, MD, PhD1; Nathaniel L. Melton, MD1; Behzad Soleimani, MD1
doi : 10.1001/jama.2020.20542
JAMA. 2020;324(21):2214-2215
Developments in Heart Failure With Reduced Ejection Fraction
Ricky D. Turgeon, BSc(Pharm), ACPR, PharmD1; Arden R. Barry, BSc, BSc(Pharm), PharmD, ACPR1
doi : 10.1001/jama.2020.20545
JAMA. 2020;324(21):2215
Developments in Heart Failure With Reduced Ejection Fraction—Reply
Sean P. Murphy, MB, BCh, BAO1; Nasrien E. Ibhrahim, MD1; James L. Januzzi Jr, MD1
doi : 10.1001/jama.2020.20548
JAMA. 2020;324(21):2215-2216
